A detailed history of Envestnet Asset Management Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 299,668 shares of EXAS stock, worth $17.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
299,668
Previous 326,910 8.33%
Holding current value
$17.4 Million
Previous $13.8 Million 47.74%
% of portfolio
0.01%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$42.43 - $70.83 $1.16 Million - $1.93 Million
-27,242 Reduced 8.33%
299,668 $20.4 Million
Q2 2024

Aug 08, 2024

SELL
$41.33 - $74.26 $447,438 - $803,938
-10,826 Reduced 3.21%
326,910 $13.8 Million
Q1 2024

May 13, 2024

SELL
$56.27 - $73.77 $3.58 Million - $4.69 Million
-63,594 Reduced 15.85%
337,736 $23.3 Million
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $2.04 Million - $2.62 Million
34,540 Added 9.42%
401,330 $29.7 Million
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $2.83 Million - $4.25 Million
42,896 Added 13.24%
366,790 $25 Million
Q2 2023

Aug 04, 2023

SELL
$62.68 - $95.05 $273,284 - $414,418
-4,360 Reduced 1.33%
323,894 $30.4 Million
Q1 2023

May 11, 2023

SELL
$47.19 - $70.77 $1.21 Million - $1.81 Million
-25,570 Reduced 7.23%
328,254 $22.3 Million
Q4 2022

Feb 07, 2023

BUY
$30.35 - $53.15 $1.3 Million - $2.27 Million
42,712 Added 13.73%
353,824 $17.5 Million
Q3 2022

Nov 10, 2022

SELL
$31.97 - $49.37 $97,924 - $151,220
-3,063 Reduced 0.97%
311,112 $10.1 Million
Q2 2022

Aug 03, 2022

SELL
$35.61 - $76.23 $299,871 - $641,932
-8,421 Reduced 2.61%
314,175 $12.4 Million
Q1 2022

May 04, 2022

SELL
$57.56 - $82.54 $1.2 Million - $1.72 Million
-20,851 Reduced 6.07%
322,596 $22.6 Million
Q4 2021

Feb 04, 2022

BUY
$72.5 - $100.68 $3.22 Million - $4.47 Million
44,414 Added 14.85%
343,447 $26.7 Million
Q3 2021

Oct 07, 2021

BUY
$90.24 - $124.05 $4.13 Million - $5.67 Million
45,744 Added 18.06%
299,033 $28.5 Million
Q2 2021

Aug 04, 2021

BUY
$93.66 - $139.27 $3.12 Million - $4.64 Million
33,301 Added 15.14%
253,289 $31.5 Million
Q1 2021

May 04, 2021

BUY
$116.57 - $155.01 $6.67 Million - $8.87 Million
57,204 Added 35.14%
219,988 $29 Million
Q4 2020

Feb 02, 2021

BUY
$99.61 - $142.12 $3.23 Million - $4.61 Million
32,448 Added 24.9%
162,784 $21.6 Million
Q3 2020

Oct 09, 2020

BUY
$72.92 - $102.01 $6.89 Million - $9.64 Million
94,492 Added 263.62%
130,336 $13.3 Million
Q2 2020

Jul 08, 2020

SELL
$55.75 - $92.75 $144,782 - $240,871
-2,597 Reduced 6.76%
35,844 $3.12 Million
Q1 2020

Apr 23, 2020

SELL
$37.9 - $104.44 $203,826 - $561,678
-5,378 Reduced 12.27%
38,441 $2.23 Million
Q4 2019

Feb 11, 2020

BUY
$77.66 - $99.74 $1.1 Million - $1.41 Million
14,152 Added 47.7%
43,819 $4.05 Million
Q3 2019

Oct 17, 2019

BUY
$90.37 - $122.49 $511,223 - $692,925
5,657 Added 23.56%
29,667 $2.68 Million
Q2 2019

Aug 02, 2019

BUY
$89.51 - $118.04 $211,333 - $278,692
2,361 Added 10.91%
24,010 $2.83 Million
Q1 2019

May 10, 2019

SELL
$61.98 - $96.5 $90,738 - $141,276
-1,464 Reduced 6.33%
21,649 $1.88 Million
Q4 2018

Feb 13, 2019

BUY
$56.04 - $82.66 $691,085 - $1.02 Million
12,332 Added 114.39%
23,113 $1.46 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $394,142 - $657,857
8,162 Added 311.65%
10,781 $851,000
Q2 2018

Aug 10, 2018

BUY
$37.84 - $69.96 $681 - $1,259
18 Added 0.69%
2,619 $156,000
Q1 2018

May 09, 2018

SELL
$39.82 - $57.53 $4,937 - $7,133
-124 Reduced 4.55%
2,601 $106,000
Q4 2017

Feb 20, 2018

BUY
$46.49 - $60.51 $8,042 - $10,468
173 Added 6.78%
2,725 $143,000
Q3 2017

Nov 13, 2017

SELL
$37.05 - $47.12 $1,704 - $2,167
-46 Reduced 1.77%
2,552 $121,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,598
2,598 $92,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.